Nov 14, 2:48 AM EST

Gov't approves first-ever med with digital tracking system


WASHINGTON (AP) -- The Food and Drug Administration has approved the first drug in the United States with a digital ingestion tracking system in an unprecedented step to ensure that patients with mental disorders take the medicine prescribed for them.

The drug Abilify MyCite was developed by Otsuka Pharmaceutical Co., Ltd. Abilify was first approved by the FDA in 2002 to treat schizophrenia, and the ingestible sensor, made by Proteus Digital health, was initially approved for marketing in 2012. The agency says the digitally enhanced medication "works by sending a message from the pill's sensor to a wearable patch."

Dr. Mitchell Mathis of the FDA says officials support "use of new technology in prescription drugs and is committed to working with companies to understand how the new technology might benefit patients and prescribers."

© 2017 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed. Learn more about our Privacy Policy and Terms of Use.

Visit zip2save.com for all your favorite circulars & coupons!
Search Wicked Local Businesses
Search for: 
In City or Town: 

Top Ads


Site Services
Subscribe
E-edition
Contact Us
Market Place
Classifieds
Jobs
Cars
Read Estate
Shopping
Coupons
Sports
Pro
Youth
College
Intramural
Outdoors
Lifestyle
Home & Garden
Food
Health
Movies
Music